search
Back to results

High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes

Primary Purpose

Pre-diabetes

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Intervention
Sponsored by
Diabetes Foundation, India
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pre-diabetes

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Exclusion Criteria: Acute infections and advanced end-organ damage. History of hepatitis or pancreatitis, abnormal liver and renal function tests. Recent (<3 months) changes in weight (≥5%) and/or weight changing medications. Subjects with metallic implants, pacemaker leads, radioactive seeds or surgical staples in the body. Inclusion Criteria Cases: Age 18 to 50 years. Subjects with pre-diabetes on oral glucose tolerance test (OGTT) Fasting blood glucose≥100mg/dl and <126 mg/dl or 2-h plasma glucose ≥140mg/dl and <200mg/dl (after ingestion of 75 grams of anhydrous oral glucose) or both. Controls: Age 18 to 50 years. Normoglycemia by OGTT Fasting blood glucose <100mg/dl and 2-h plasma glucose <140mg/dl (after ingestion of 75 gram of anhydrous oral glucose).

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Other

    Arm Label

    High Protein Diet

    Control Group

    Arm Description

    High protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods. All assessments as done on day 1 will be repeated on day 60.

    Equicaloric normal diet (carbohydrates 60%, protein 15%, and fat 25%)

    Outcomes

    Primary Outcome Measures

    Body Mass Index
    BMI will be calculated by using formula weight (Kg)/height (m2).
    Body Fat
    Body estimations will be done by DEXA Scan
    Liver Fat
    Liver fat will be done by MRI Scan
    Next Generation sequencing
    Pancreatic fat
    Pancreatic fat estimation will be done by MRI
    RNA Extraction
    Metabolomics profile

    Secondary Outcome Measures

    Full Information

    First Posted
    June 13, 2023
    Last Updated
    June 22, 2023
    Sponsor
    Diabetes Foundation, India
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05925933
    Brief Title
    High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
    Official Title
    Effect of High Protein Diet on Transcriptomic Regulations, Plasma Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 1, 2023 (Anticipated)
    Primary Completion Date
    September 30, 2026 (Anticipated)
    Study Completion Date
    October 31, 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Diabetes Foundation, India

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Diabetes/ prediabetes is a substantial problem in India not only because it itself can be associated with morbidities such as coronary artery disease but also because it is a point of importance for the prevention of other diseases. It is not clear if a high protein calorie diet in the Indian population associated with a heightened tendency for prediabetes, metabolic syndrome, atherosclerosis and dysmetabolic state etc. could, besides lifestyle factors, be related to diet, or interaction between the two. The analysis of whole blood transcriptomes and plasma metabolomics profiles may be a potentially useful tool for the assessment of metabolic health status. The proposed study is the first to perform a detailed gene expression profiling with the use of next-generation sequencing technology to assess the differences in molecular mechanisms in the peripheral blood of subjects with prediabetes.
    Detailed Description
    This study will be conducted at the outpatient department of the National Diabetes, Obesity and Cholesterol Foundation (N-DOC), Diabetes Foundation (India) (DFI)and Fortis-C-DOC, Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India. Experimental Protocol: In this study, a total of 60 subjects with pre-diabetes and 60 age and body mass index, and gender-matched controls (age 18-40 years) will be recruited. They will be randomized to an equicaloric normal diet (carbohydrates 60%, protein 15%, and fat 25%) or a high protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods. All assessments as done on day 1 will be repeated at day 60.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pre-diabetes

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    High Protein Diet
    Arm Type
    Experimental
    Arm Description
    High protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods. All assessments as done on day 1 will be repeated on day 60.
    Arm Title
    Control Group
    Arm Type
    Other
    Arm Description
    Equicaloric normal diet (carbohydrates 60%, protein 15%, and fat 25%)
    Intervention Type
    Other
    Intervention Name(s)
    Intervention
    Intervention Description
    high protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods.
    Primary Outcome Measure Information:
    Title
    Body Mass Index
    Description
    BMI will be calculated by using formula weight (Kg)/height (m2).
    Time Frame
    6 Months
    Title
    Body Fat
    Description
    Body estimations will be done by DEXA Scan
    Time Frame
    2 MONTHS
    Title
    Liver Fat
    Description
    Liver fat will be done by MRI Scan
    Time Frame
    2 Months
    Title
    Next Generation sequencing
    Time Frame
    06 MONTHS
    Title
    Pancreatic fat
    Description
    Pancreatic fat estimation will be done by MRI
    Time Frame
    06 MONTHS
    Title
    RNA Extraction
    Time Frame
    06 MONTHS
    Title
    Metabolomics profile
    Time Frame
    06 MONTHS

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Exclusion Criteria: Acute infections and advanced end-organ damage. History of hepatitis or pancreatitis, abnormal liver and renal function tests. Recent (<3 months) changes in weight (≥5%) and/or weight changing medications. Subjects with metallic implants, pacemaker leads, radioactive seeds or surgical staples in the body. Inclusion Criteria Cases: Age 18 to 50 years. Subjects with pre-diabetes on oral glucose tolerance test (OGTT) Fasting blood glucose≥100mg/dl and <126 mg/dl or 2-h plasma glucose ≥140mg/dl and <200mg/dl (after ingestion of 75 grams of anhydrous oral glucose) or both. Controls: Age 18 to 50 years. Normoglycemia by OGTT Fasting blood glucose <100mg/dl and 2-h plasma glucose <140mg/dl (after ingestion of 75 gram of anhydrous oral glucose).
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Anoop Misra, MD
    Phone
    01149101222
    Email
    anoopmisra@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Surya Prakash, PhD+Post Doc
    Phone
    01141759672
    Email
    suryabhat@gmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    In this study a total of 60 subjects with pre-diabetes and 60 age and body mass index, and gender matched controls (age 18-40 years) will be recruited. They will be randomized to an equicaloric normal diet or high protein diet over 8-week periods. All assessments as done on day 1 will be repeated on day 60.

    Learn more about this trial

    High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes

    We'll reach out to this number within 24 hrs